TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,495,433 | -6.1% | 2,294,469 | -4.7% | 0.00% | 0.0% |
| Q2 2023 | $37,812,385 | -9.9% | 2,406,899 | -5.5% | 0.00% | 0.0% |
| Q1 2023 | $41,958,346 | +28.9% | 2,546,016 | +22.1% | 0.00% | 0.0% |
| Q4 2022 | $32,539,038 | +12.5% | 2,085,836 | -6.5% | 0.00% | 0.0% |
| Q3 2022 | $28,936,000 | -5.4% | 2,230,997 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $30,576,000 | -29.3% | 2,177,763 | -27.9% | 0.00% | 0.0% |
| Q1 2022 | $43,265,000 | +45.7% | 3,021,274 | +38.6% | 0.00% | 0.0% |
| Q4 2021 | $29,701,000 | -0.0% | 2,179,135 | +20.1% | 0.00% | 0.0% |
| Q3 2021 | $29,713,000 | +5.4% | 1,813,949 | +8.3% | 0.00% | 0.0% |
| Q2 2021 | $28,199,000 | +12.9% | 1,675,527 | +22.5% | 0.00% | 0.0% |
| Q1 2021 | $24,980,000 | +192053.8% | 1,368,005 | +196170.4% | 0.00% | – |
| Q4 2020 | $13,000 | +8.3% | 697 | +5.9% | 0.00% | – |
| Q3 2020 | $12,000 | +1100.0% | 658 | +897.0% | 0.00% | – |
| Q4 2019 | $1,000 | -80.0% | 66 | -78.2% | 0.00% | – |
| Q3 2019 | $5,000 | -88.4% | 303 | -87.7% | 0.00% | – |
| Q2 2019 | $43,000 | +138.9% | 2,461 | +174.1% | 0.00% | – |
| Q1 2019 | $18,000 | +500.0% | 898 | +398.9% | 0.00% | – |
| Q4 2018 | $3,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |